EMA committee recommends repotrectinib for lung cancer
Opthea adds Kathy Connell to Board of Directors
Palantir launches new developer tools at inaugural DevCon
Eyenovia halts myopia study after missing primary endpoint
Polar Power announces reverse stock split to meet Nasdaq requirements
Sandoz receives European Commission approval for Afqlir® (aflibercept), further strengthening leading biosimilar portfolio
Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
Harrow Announces Participation in Upcoming Investor Conferences
Bio-Path Holdings Reports Third Quarter 2024 Financial Results
Precision BioSciences Highlights Preclinical Data and Outlines Design of First-in-Human Clinical Trial for PBGENE-HBV for Treatment of Chronic Hepatitis B